查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390682

羊膜市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球羊膜市場規模達14億美元。展望未來， IMARC Group預計到2028年市場規模將達到24億美元，2022-2028年複合年成長率（CAGR）為9.40%。對微創（MI）治療的日益青睞、糖尿病和類風濕關節炎等多種慢性疾病的盛行率上升，以及專科診所和醫院的擴張是推動市場的一些主要因素。

羊膜是胎盤的最內層，由厚的基底膜和無血管基質組成。它是一種源自胎盤的生物組織，由於其獨特的特性而用於醫療應用。它透過調節發炎反應來減少炎症，並最大限度地減少組織中的纖維化和疤痕。它可以舒緩疼痛的傷口和燒傷，並縮短其癒合時間。它安全且耐受性良好，排斥率低，廣泛用於角膜潰瘍等眼表疾病的手術。它還用作生物敷料，以減少粘連並促進恢復。

人們對微創 (MI) 治療的日益青睞導致羊膜在各種外科手術中的利用率不斷提高。此外，醫療基礎設施的成長以及專科診所和醫院的擴張為羊膜療法的實施提供了更多機會。除此之外，各種領先的市場參與者都專注於併購（M&A），以擴大影響力、分享專業知識並進入新市場。此外，公司正在積極使其產品線多樣化，提供適合各種手術和治療需求的羊膜。此外，一些國家的政府正在加強對醫療保健專業人員和患者進行有關羊膜的好處和應用的教育，這提供了良好的市場前景。

羊膜市場趨勢/促進因素：

對再生醫學的需求不斷增加

糖尿病和類風濕性關節炎等幾種慢性疾病的盛行率不斷上升，導致慢性傷口和潰瘍，增加了對有效治療方法的需求。羊膜提供了一種創新的解決方案並刺激癒合過程。除此之外，全球老年人口不斷成長，極易受到各種健康狀況的影響，這推動了對促進更快癒合和組織再生的治療的需求。此外，骨科和牙科等各種醫學專業擴大採用羊膜，這對市場產生了積極影響。此外，羊膜促進細胞生長和減少發炎的能力正在推動其在其他再生治療中的採用。

醫療程序的技術進步

先進技術的整合正在導致羊膜的開發提高效率和功效。現代技術確保維持必需的生長因子和癒合特性，從而增強其在各個醫學領域的適用性。羊膜與幹細胞療法和3D（3D）生物列印等尖端治療方法的兼容性提供了良好的市場前景。這些整合可以實現更個人化和有效的治療，並提高患者護理的品質。除此之外，改進的保存方法允許更長的保存期限和更廣泛的分銷，這正在增加其在各個地區和醫療保健系統中的採用。

支持性監管環境

各國監管機構正在認知到羊膜的治療價值，並針對羊膜的提取、加工、保存和應用實施明確且明確的指南。這些準則確保實踐的一致性並維護產品的品質。除此之外，監管機構正在積極監控市場，以確保遵守所有相關規則和標準。定期檢查、審計和報告要求有助於維護行業的信任和誠信。此外，他們還提供支持性政策，包括贈款、激勵措施和公私合作夥伴關係，鼓勵該領域的研究和發展。與研究機構的合作可以推動創新並將新穎的產品和療法推向市場。

羊膜產業細分：

IMARC Group提供了全球羊膜市場報告各細分市場的主要趨勢分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用戶對市場進行了分類。

按產品分類：

冷凍保存羊膜

凍乾羊膜

凍存羊膜佔據市場主導地位

該報告根據產品提供了詳細的市場細分和分析。這包括冷凍保存的羊膜和冷凍乾燥羊膜。根據該報告，冷凍保存的羊膜代表了最大的部分。

它的保存期限很長，可以讓醫院和診所保持庫存，而不會有分解的風險。它還易於儲存、簡化物流並減少浪費。此外，它有助於維持羊膜的生物完整性並增強羊膜的治療效果。這種保留自然癒合特性的能力吸引了醫療保健提供者。除此之外，監管機構正在認知到低溫保存的好處，並積極提供支持性指導方針和批准。監管機構的支持正在促進不同地區採用冷凍羊膜。

按應用分類：

手術傷口

眼科

其他

手術傷口佔大部分市場佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括手術傷口、眼科傷口等。報告稱，手術傷口佔據了大部分市場。不斷增加的道路事故和重大運動傷害導致各個醫學學科的擇期手術和緊急手術數量增加，從而促進了對有效傷口護理的需求。此外，外科手術的技術進步使得更複雜和更多的手術能夠以最佳效率進行。除此之外，人們越來越關注盡量減少術後感染和併發症，這推動了對高品質傷口護理產品的需求。人們越來越意識到感染預防和控制的重要性，這鼓勵醫療保健提供者和患者選擇最佳的傷口護理解決方案。此外，人們越來越注重有效癒合且不留明顯疤痕，這導致了專門為手術傷口設計的傷口護理產品的創新。

按最終用戶分類：

醫院

門診手術中心

專科診所

研究中心和實驗室

醫院佔最大市場佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、門診手術中心、專科診所、研究中心和實驗室。報告顯示，醫院佔據了最大的市場。他們擁有專門的醫療專業人員和訓練有素的工作人員來處理各種醫療狀況。由於配備了技術先進的醫療設備，他們可以提供增強的診斷和治療程序。除此之外，他們還提供緊急醫療服務並處理緊急和危及生命的情況，這提供了良好的市場前景。此外，許多醫院與保險公司建立了關係，為患者提供更輕鬆、更全面的保險，這使得許多人更容易獲得醫院護理。此外，各地區的醫院都得到政府的資助和支持，這確保了更廣泛的人群獲得基本的醫療服務。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的羊膜市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據了最大的市場佔有率，因為該地區擁有領先的研究機構和生物技術公司，積極投資於包括羊膜在內的再生醫學的研發（R＆D）活動。此外，該地區擁有高度發展的醫療保健系統，擁有最先進的設施和技術，推動創新並促進羊膜等先進醫療產品的採用。除此之外，北美針對羊膜產品開發、批准和使用的支持性監管指南正在鼓勵製造商擴大其市場範圍。此外，醫院、研究機構和生物技術公司之間的合作正在增強該地區的創新和市場滲透。

競爭格局：

該公司目前正在進行各種活動，以擴大這種獨特生物材料的範圍和效率。他們從胎盤中提取羊膜，並在嚴格控制的條件下進行處理。此外，他們正在進行嚴格的研發，探索羊膜在再生醫學中應用的新可能性。除此之外，他們還不斷努力增強羊膜的潛力，改善新療法的前景，並繼續支持醫療保健和患者福祉的更廣泛目標。此外，許多公司積極參與對醫療保健提供者進行有關羊膜的好處和應用的教育。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

羊膜科技有限公司

Amniox 醫療公司（TissueTech 公司）

創世紀生物製品公司

人類再生技術有限公司

Integra生命科學控股公司

卡泰納產品公司

米邁德克斯集團

下一個生物科學公司

斯凱生物製品控股有限公司

全錄輝公司

Surgenex有限責任公司

文特里斯醫療有限公司

萊特醫療集團 (Stryker BV)。

最近的發展：

2022 年 2 月，Amnio Technology LLC 推出了兩款新的 PalinGen 膜產品：PalinGen 雙層膜和雙層 PalinGen X-膜。它們的操作最少、同源使用且不含絨毛膜。

2021 年 6 月，MiMedx 集團在日本獲得報銷批准，成為該國第一個也是唯一一個獲準使用的羊膜組織產品。

本報告回答的關鍵問題

  • 2022年全球羊膜市場規模是多少
  • 2023-2028年全球羊膜市場的預期成長率是多少
  • 推動全球羊膜市場的關鍵因素是什麼
  • COVID-19 對全球羊膜市場有何影響
  • 基於產品的全球羊膜市場區隔是怎樣的
  • 基於應用的全球羊膜市場區隔如何
  • 基於最終用戶的全球羊膜市場的細分如何
  • 全球羊膜市場的重點區域有哪些
  • 誰是全球羊膜市場的主要參與者/公司

本報告回答的關鍵問題

  • 2022年全球羊膜市場規模有多大？
  • 2023-2028年全球羊膜市場的預期成長率是多少？
  • 推動全球羊膜市場的關鍵因素是什麼？
  • COVID-19 對全球羊膜市場有何影響？
  • 基於產品的全球羊膜市場區隔如何？
  • 全球羊膜市場基於應用的詳細情形如何？
  • 基於最終用戶的全球羊膜市場的詳細情形如何？
  • 全球羊膜市場的重點區域有哪些？
  • 全球羊膜市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球羊膜市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 冷凍保存羊膜
    • 市場走向
    • 市場預測
  • 凍乾羊膜
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 手術傷口
    • 市場走向
    • 市場預測
  • 眼科
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 研究中心和實驗室
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amnio Technology LLC
    • Amniox Medical Inc. (TissueTech Inc.)
    • Genesis Biologics
    • Human Regenerative Technologies LLC
    • Integra LifeSciences Holdings Corporation
    • Katena Products Inc.
    • MiMedx Group
    • Next Biosciences
    • Skye Biologics Holdings LLC
    • Smith & Nephew plc
    • Surgenex LLC
    • Ventris Medical LLC
    • Wright Medical Group NV (Stryker BV)
Product Code: SR112023A4503

Abstract

The global amniotic membrane market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2022-2028. The increasing preference for minimally invasive (MI) treatments, rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, and the expansion of specialized clinics and hospitals are some of the major factors propelling the market.

The amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It is a biological tissue derived from the placenta and utilized in medical applications due to its unique properties. It reduces inflammation by modulating inflammatory responses and minimizes fibrosis and scarring in tissues. It provides a soothing effect on painful wounds and burns and reduces their healing times. It is safe and well-tolerated, with low rejection rates and widely used in surgeries for ocular surface disorders, such as corneal ulcers. It is also employed as a biological dressing to reduce adhesions and enhance recovery.

The increasing preference for minimally invasive (MI) treatments is resulting in the increasing utilization of the amniotic membrane in various surgical procedures. Additionally, growth in healthcare infrastructure and the expansion of specialized clinics and hospitals are offering more opportunities for the implementation of amniotic membrane therapies. Apart from this, various leading market players are focusing on mergers and acquisitions (M&A) to expand their reach, share expertise, and access new markets. Furthermore, companies are actively diversifying their product lines, offering amniotic membranes tailored for various surgical and therapeutic needs. Moreover, governments of several countries are increasing their efforts to educate healthcare professionals and patients about the benefits and applications of amniotic membranes, which is offering a favorable market outlook.

Amniotic Membrane Market Trends/Drivers:

Increasing demand for regenerative medicine

The rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, leading to chronic wounds and ulcers is increasing the need for effective treatment methods. Amniotic membranes offer an innovative solution and stimulate the healing process. Apart from this, the growing global geriatric population, which is highly susceptible to various health conditions is driving the need for treatments that promote faster healing and tissue regeneration. Furthermore, the increasing adoption of amniotic membranes in various medical specialties like orthopedics and dental medicine is positively influencing the market. Moreover, the ability of the amniotic membrane to facilitate cellular growth and decrease inflammation is driving its adoption in other regenerative treatments.

Technological advancements in medical procedures

The integration of advanced technologies is resulting in the development of amniotic membranes with increased efficiency and efficacy. Modern techniques ensure that essential growth factors and healing properties are maintained, enhancing their applicability in various medical domains. The compatibility of the amniotic membrane with cutting-edge treatments, such as stem cell therapies and three-dimensional (3D) bioprinting, is offering a favorable market outlook. These integrations allow for more personalized and effective treatments and enhance the quality of patient care. Apart from this, improved preservation methods allow for longer shelf life and wider distribution, which is increasing its adoption across various regions and healthcare systems.

Supportive regulatory environment

Regulatory bodies of various countries are recognizing the therapeutic value of the amniotic membrane and implementing clear and well-defined guidelines for the extraction, processing, preservation, and application of amniotic membranes. These guidelines ensure uniformity in practices and uphold the quality of products. Apart from this, regulatory authorities are actively monitoring the market to ensure compliance with all relevant rules and standards. Regular inspections, audits, and reporting requirements help maintain trust and integrity in the industry. Furthermore, they are offering supportive policies, which include grants, incentives, and public-private partnerships that encourage research and development in the field. Collaborative efforts with research institutions can drive innovation and bring novel products and therapies to market.

Amniotic Membrane Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global amniotic membrane market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Cryopreserved Amniotic Membrane

Lyophilization Amniotic Membrane

Cryopreserved amniotic membrane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cryopreserved amniotic membrane and lyophilization amniotic membrane. According to the report, cryopreserved amniotic membrane represented the largest segment.

It has a long shelf life and it allows hospitals and clinics to maintain an inventory without the risk of degradation. It also offers ease of storage, simplifies logistics, and reduces waste. Additionally, it aids in maintaining the biological integrity of the amniotic membrane and enhancing the therapeutic effectiveness of the membrane. This ability to retain the natural healing properties is attracting healthcare providers. Apart from this, regulatory bodies are recognizing the benefits of cryopreservation and are actively providing supportive guidelines and approvals. This support from regulatory authorities is promoting the adoption of cryopreserved amniotic membranes across different regions.

Breakup by Application:

Surgical Wounds

Ophthalmology

Others

Surgical wounds account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes surgical wounds, ophthalmology, and others. According to the report, surgical wounds hold the majority of the market share. Increasing road accidents and major sports injuries are leading to a rise in elective and emergency surgeries across various medical disciplines, which is catalyzing the need for effective wound care. Additionally, technological advancements in surgical procedures are allowing for more complex and numerous surgeries to be performed with optimal efficiency. Apart from this, the rising focus on minimizing post-operative infections and complications is driving the demand for high-quality wound care products. The growing awareness about the importance of infection prevention and control is encouraging healthcare providers and patients to opt for optimal wound care solutions. Furthermore, rising preferences for effective healing without significant scarring is leading to innovations in wound care products specifically designed for surgical wounds.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Specialized Clinics

Research Centers and Laboratory

Hospitals hold the largest share of the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. According to the report, hospitals accounted for the largest market share. They have specialized medical professionals and skilled staff trained to deal with various medical conditions. They can offer enhanced diagnostic and therapeutic procedures as they are equipped with technologically advanced medical equipment. Apart from this, they provide emergency medical services and handle urgent and life-threatening situations, which is offering a favorable market outlook. Furthermore, many hospitals have established relationships with insurance providers, facilitating easier and more comprehensive coverage for patients, which makes hospital-based care more accessible for many individuals. Moreover, hospitals in various regions receive government funding and support, which ensures the availability of essential healthcare services to the wider population.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest amniotic membrane market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share since the region is home to leading research institutions and biotechnology companies that actively invest in the research and development (R&D) activities of regenerative medicine, including amniotic membranes. Additionally, the region has a highly developed healthcare system with state-of-the-art facilities and technology, which drives innovation and facilitates the adoption of advanced medical products, such as amniotic membranes. Apart from this, supportive regulatory guidelines for the development, approval, and use of amniotic membrane products in North America is encouraging manufacturers to expand their market reach. Furthermore, collaborations between hospitals, research institutions, and biotechnology companies is enhancing innovation and market penetration in the region.

Competitive Landscape:

Companies are currently engaging in a variety of activities to expand the scope and efficiency of this unique biological material. They are extracting the amniotic membrane from the placenta and are processing it under carefully controlled conditions. Additionally, they are conducting rigorous R&D, exploring new possibilities for amniotic membrane use in regenerative medicine. Apart from this, they are working continuously to enhance the potential of the amniotic membrane, improving the prospects of new therapies, and continuing to support the broader goals of healthcare and patient well-being. Furthermore, many companies are actively involved in educating healthcare providers about the benefits and applications of the amniotic membrane.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amnio Technology LLC

Amniox Medical Inc. (TissueTech Inc.)

Genesis Biologics

Human Regenerative Technologies LLC

Integra LifeSciences Holdings Corporation

Katena Products Inc.

MiMedx Group

Next Biosciences

Skye Biologics Holdings LLC

Smith & Nephew plc

Surgenex LLC

Ventris Medical LLC

Wright Medical Group N.V. (Stryker B.V.).

Recent Developments:

In February 2022, Amnio Technology LLC launched two new PalinGen membrane products, PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. They are minimally manipulated, homologous use and chorion-free.

In June 2021, MiMedx Group received reimbursement approval in Japan, making it the first and only amniotic tissue product approved for use in the country.

Key Questions Answered in This Report

  • 1. What was the size of the global amniotic membrane market in 2022?
  • 2. What is the expected growth rate of the global amniotic membrane market during 2023-2028?
  • 3. What are the key factors driving the global amniotic membrane market?
  • 4. What has been the impact of COVID-19 on the global amniotic membrane market?
  • 5. What is the breakup of the global amniotic membrane market based on the product?
  • 6. What is the breakup of the global amniotic membrane market based on the application?
  • 7. What is the breakup of the global amniotic membrane market based on the end user?
  • 8. What are the key regions in the global amniotic membrane market?
  • 9. Who are the key players/companies in the global amniotic membrane market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amniotic Membrane Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cryopreserved Amniotic Membrane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lyophilization Amniotic Membrane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgical Wounds
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ophthalmology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialized Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Centers and Laboratory
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amnio Technology LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Amniox Medical Inc. (TissueTech Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genesis Biologics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Human Regenerative Technologies LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Integra LifeSciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Katena Products Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MiMedx Group
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Next Biosciences
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Skye Biologics Holdings LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Surgenex LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Ventris Medical LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wright Medical Group N.V. (Stryker B.V.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Amniotic Membrane Market: Major Drivers and Challenges
  • Figure 2: Global: Amniotic Membrane Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Amniotic Membrane Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Amniotic Membrane Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Amniotic Membrane Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Amniotic Membrane Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Amniotic Membrane Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Amniotic Membrane (Surgical Wounds) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Amniotic Membrane (Surgical Wounds) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Amniotic Membrane (Ophthalmology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Amniotic Membrane (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Amniotic Membrane (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Amniotic Membrane (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Amniotic Membrane (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Amniotic Membrane (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Amniotic Membrane (Specialized Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Amniotic Membrane (Specialized Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Amniotic Membrane (Research Centers and Laboratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Amniotic Membrane (Research Centers and Laboratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Amniotic Membrane Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Amniotic Membrane Industry: SWOT Analysis
  • Figure 76: Global: Amniotic Membrane Industry: Value Chain Analysis
  • Figure 77: Global: Amniotic Membrane Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amniotic Membrane Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Amniotic Membrane Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Amniotic Membrane Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Amniotic Membrane Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Amniotic Membrane Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Amniotic Membrane Market: Competitive Structure
  • Table 7: Global: Amniotic Membrane Market: Key Players